NCT06202690Not yet recruiting
SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC
Single-POrt Robotic Versus Video-assisted Thoracic Surgery Anatomical Pulmonary Resection for Patients With Non-small Cell Lung Cancer (SPORTS Study): a Single-center, Single-blinded, Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 11 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Single-POrt Robotic-assisted thoracic surgery versus single-port video-assisted Thoracic Surgery major pulmonary resection for patients with non-small cell lung cancer (SPORTS trial): a single-center, a single blinded, randomized controlled trial
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 290 (estimated)
- First submitted
- 9 Nov 2023
- Start date
- 9 Jan 2024
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- Korea University Guro Hospital
- Diseases
- Lung cancer
- NCT number
- NCT06202690
What you commit to
- Study type: Interventional
- Planned participants: 290
- From 9 Jan 2024 to the primary completion date, 30 Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who specifically desire a certain surgical method (robotic, thoracoscopic, open thoracotomy)
- Patients who previously undergone a thoracic surgical procedure in the hemithorax to be operated on
- Patients who received neoadjuvant therapy.
- Candidate for pneumonectomy, bilobectomy, lobectomy plus segmentectomy, non-anatomic resection (ex, wedge resection).
Other illness
- Patients who require surgery for accompanying other organ diseases
- Pathological results other than NSCLC (ex, benign nodules, metastatic lung cancer, SCLC)
- History of other cancers in the past 5 years.
Other
- Tumor invasion into the chest wall, diaphragm, another lobe or diaphragm
- Patients who are considered unsuitable based on the researcher's judgment
- Patients with cognitive impairments who are unable to understand the instructions and informed consent of this study
Who the study is looking for
- Candidate for anatomical pulmonary resection (segmentectomy or lobectomy) via minimally invasive thoracic surgery (RATS or VATS) for patient with non-small cell lung cancer or suspected malignant lesion.
- Age ≥ 18 years
- Patients who can comply with the requirements of the clinical trial and who, or their legal representatives, provide written consent before the start of the clinical trial
- Patients with the nationality of South Korea
- American Society of Anesthesiologists score 1-3.
- Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.